Journals / Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi / 2017 / Cilt: 20 - Sayı: 1

Evaluation of Urinary Tract Infections After Stroke: Review

İnme Sonrası Görülen İdrar Yolu Enfeksiyonlarının Değerlendirilmesi

Pages
31–36
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further research is needed to develop effective patient follow-up strategies to decrease this important complication in the stroke population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Urinary tract infection (UTI) is a common complication in patients with stroke.
📊
Key Findings & Data:Incidence of UTI in after stroke varies from 3% to 44%.
💡
Conclusion & Impact:Further research is needed to develop effective patient follow-up strategies to decrease this important complication in the stroke population.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Urinary tract infection (UTI) is a common complication in patients with stroke. Incidence of UTI in after stroke varies from 3% to 44%. UTIs after stroke are preventable to an extent. This article explores the pathophysiology, risk factors for, and consequences of UTI and possible methods to reduce its incidence after stroke. Patients with stroke are particularly vulnerable to UTI due to increased risk from immunosuppression, bladder dysfunction, and increased indwelling urinary catheter use. Adverse effects of UTI on stroke recovery are multifactorial. UTI is associated with poorer neurological outcomes, longer hospital stays, and increased cost of care after stroke. Intervention strategies previously attempted in this population include prophylactic antibiotics, antiseptic-impregnated catheters, and quality improvement methods to reduce inappropriate catheterization. Careful evaluation of bladder functions and individualized management of each patient is necessary for optimal results. Patients with stroke have different risks for, consequences of, and barriers to reduce UTI than other patients. Further research is needed to develop effective patient follow-up strategies to decrease this important complication in the stroke population.

Özet

İdrar yolu enfeksiyonu (İYE) inmeli hastalarda sık görülen bir komplikasyondur. İnme sonrası İYE insidansı %3-44 arasında değişmektedir. İnme sonrası İYE bir ölçüde önlenebilmektedir. Bu çalışmada, inme sonrası görülen İYE’nin patofizyolojisi, risk faktörleri, sonuçları ve inmeli populasyonda İYE insidansını azaltmaya yönelik olası yöntemler tartışılmıştır. İmmünsüpresyon, mesane disfonksiyonu ve artmış kalıcı idrar sondası kullanımına bağlı olarak inmeli hastalar İYE için artmış risk altındadır. İYE’nin inme sonrası iyileşmeye olumsuz etkileri multifaktöriyeldir. İnme sonrası İYE kötü nörolojik sonuçlar, daha uzun süreli hastanede yatış ve artmış bakım maliyeti ile ilişkilidir. Daha önce bu populasyonda denenmiş müdahale stratejileri; profilaktik antibiyotik, antibiyotikle kaplanmış sonda kullanımı ve uygunsuz kalıcı idrar sondası kullanımını azaltacak kalite geliştirme yöntemlerini içermektedir. Mesane fonksiyonlarının dikkatli değerlendirilmesi ve her hastanın bireysel olarak ele alınması optimal sonuçlar için gereklidir. İnmeli hastalarda İYE’nin azaltılmasının farklı riskleri, sonuçları ve engelleri vardır. İnmeli hasta grubunda bu önemli komplikasyonu azaltmaya yönelik etkili hasta izlem stratejilerini geliştirmek için daha fazla araştırma gereklidir.

🔖

Cite This Article

CİVELEK, G. M., AFŞAR, S. İ. (2017). Evaluation of Urinary Tract Infections After Stroke: Review. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, Cilt: 20 - Sayı: 1, 31–36. https://ajindex.com/articles/173375

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Doshi VS, Say JH, Young SH, Doraisamy P. Complications in stroke patients: a study carried out at the Rehabilitation Medicine Service, Changi General Hospital. Singapore Med J 2003;44(12):643-52.
  2. Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications after acute stroke. Stroke 1996;27(3):415-20.
  3. Rocco A, Pasquini M, Cecconi E, Sirimarco G, Ricciardi MC, Vicenzini E, et al. Monitoring after the acute stage of stroke: a prospective study. Stroke 2007;38(4):1225-8.
  4. Stott DJ, Falconer A, Miller H, Tilston JC, Langhorne P. Urinary tract infection after stroke. QJM 2009;102(4):243-9.
  5. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol 2004;11(1):49-53.
  6. Hamidon BB, Raymond AA, Norlinah MI, Jefferelli SB. The predictors of early infection after an acute ischaemic stroke. Singapore Med J 2003;44(7):344-6.
  7. Indredavik B, Rohweder G, Naalsund E, Lydersen S. Medical complications in a comprehensive stroke unit and an early supported discharge service. Stroke 2008;39(2):414-20.
  8. Dromerick AW, Edwards DF. Relation of postvoid residual to urinary tract infection during stroke rehabilitation. Arch Phys Med Rehabil 2003;84(9):1369-72.
  9. Matz K, Keresztes K, Tatschl C, Nowotny M, Dachenhausen A, Brainin M, et al. Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. Diabetes Care 2006;29(4):792-7.
  10. Poisson SN, Johnston SC, Josephson SA. Urinary tract infections complicating stroke: mechanisms, consequences, and possible solutions. Stroke 2010;41(4):e180-4. Ersoz M, Ulusoy H, Oktar MA, Akyuz M. Urinary tract infection and bacteriurua in stroke patients: frequencies, pathogen microorganisms, and risk factors. Am J Phys Med Rehabil 2007;86(9):734-41.
  11. Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009;158(3):1098- 111. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003;198(5):725-36.
  12. Klehmet J, Harms H, Richter M, Prass K, Volk HD, Dirnagl U, et al. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 2009;158(3): 1184-9